S Tommasoni studies a range of cancer-related topics, including how kidney cancer can spread to the pancreas and be misdiagnosed as another tumor type. Their research involves evaluating the risks of developing new cancers after treatments, exemplified by studies on breast cancer survivors. Tommasoni also investigates specific tumor characteristics in ovarian cancers, such as mature teratomas and serous borderline tumors, to improve diagnosis and treatment approaches. Additionally, they have worked on unique cases involving rarer tumors found in children and adults, thereby broadening the understanding of both common and uncommon malignancies.
Key findings
In a study on kidney cancer spread to the pancreas, the use of ultrasound-guided needle biopsy accurately diagnosed this condition, improving treatment choices.
Two breast cancer survivors developed new bone marrow cancers 15 years post-chemotherapy, highlighting the need for monitoring secondary cancers during follow-up.
In a study of 57 ovarian mucinous tumor cases, all patients had positive outcomes more than 5 years after surgery, indicating favorable prognoses for early-stage tumors.
For serous borderline tumors of the ovary, most patients remained tumor-free for 1 to 14 years post-surgery, although those with invasive peritoneal implants faced higher mortality risks.
In a successful case of angiomatoid malignant fibrous histiocytoma, a 10-year-old girl was tumor-free four years after surgical treatment, demonstrating effective management of this rare tumor.
Frequently asked questions
Does S Tommasoni study kidney cancer?
Yes, S Tommasoni researches kidney cancer and its potential to spread to the pancreas, improving diagnosis and treatment strategies.
What types of tumors has S Tommasoni researched?
S Tommasoni has researched various tumors, including those in the ovaries, pancreas, and testicles, focusing on their characteristics and outcomes.
Is S Tommasoni's work relevant for breast cancer survivors?
Yes, S Tommasoni's findings are important for breast cancer survivors, particularly concerning the risk of developing secondary cancers after treatment.
What treatments does S Tommasoni study?
S Tommasoni studies diagnostic techniques like ultrasound-guided biopsies and surgical treatments for different cancers to enhance patient outcomes.
How does S Tommasoni's research help patients?
The research provides insights into cancer diagnosis, treatment decisions, and the long-term outcomes of various tumors, aiding both patients and healthcare providers.
Publications in plain English
Metastatic renal cell carcinoma of the pancreas mimicking neuroendocrine tumor diagnosed by endoscopic ultrasound-guided needle biopsy.
2021
Clinical case reports
De Luca L, Tommasoni S, Mangiavillano B, Repici A
Plain English This study looked at cases where kidney cancer spreads to the pancreas and can sometimes appear like a different type of tumor. The researchers found that using a special needle biopsy during an ultrasound can accurately identify this rare condition. This is important because correctly diagnosing kidney cancer that has spread to the pancreas can lead to better treatment decisions.
Who this helps: This helps patients with kidney cancer and their doctors in identifying and treating advanced disease.
Secondary bone marrow malignancies after adjuvant chemotherapy for breast cancer: a report of 2 cases and a review of the literature.
2016
Tumori
Rossi D, Sarti D, Malerba L, Tommasoni S, Visani G +2 more
Plain English This study examined two patients who developed new cancers in their bone marrow, specifically B-lymphoma and multiple myeloma, after being treated for breast cancer 15 years earlier. The findings indicate that while these new cancers occurred long after breast cancer treatment, they highlight the importance of checking for secondary cancers during follow-up care. This is crucial because it affects how doctors decide on treatment for breast cancer survivors.
Who this helps: This helps breast cancer survivors and their doctors.
Biovularity and "coalescence of primary follicles" in ovaries with mature teratomas.
2001
International journal of surgical pathology
Muretto P, Chilosi M, Rabitti C, Tommasoni S, Colato C
Plain English Researchers studied ovarian tissue from 31 women with teratomas to understand how these tumors might form. They found that 26 of the ovaries had "biovularity," meaning some follicles contained two eggs, which could indicate that these eggs merged together, leading to teratoma development. In contrast, only one ovarian case with a different condition showed a similar finding, suggesting that the merging of eggs may play a role in forming these tumors.
Who this helps: This benefits patients with ovarian teratomas and their doctors by providing insights into their origins.
Benign, borderline, and well-differentiated malignant intestinal mucinous tumors of the ovary: a clinicopathologic, histochemical, immunohistochemical, and nuclear quantitative study of 57 cases.
1994
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
de Nictolis M, Montironi R, Tommasoni S, Valli M, Pisani E +2 more
Plain English This study looked at different types of mucinous tumors in the ovaries, specifically focusing on benign tumors, borderline tumors, and early-stage malignant tumors. Researchers analyzed 57 cases and found that all patients had stage IA tumors and were doing well after more than 5 years post-surgery, which indicates a good prognosis for these early-stage tumors. They discovered that while the tumors had some differences at a microscopic level, the outcomes for patients with borderline and well-differentiated malignant tumors were quite similar, suggesting they can be treated as having the same favorable prognosis.
Who this helps: This benefits patients with early-stage ovarian tumors, as well as their doctors in making treatment decisions.
High-grade endometrial stromal sarcoma: clinicopathologic and immunohistochemical study of a case.
1994
Pathologica
De Nictolis M, Curatola A, Tommasoni S, Magiera G
Plain English This study focused on a 53-year-old woman with a rare and aggressive type of cancer called high-grade endometrial stromal sarcoma. The tumor was found in her uterus and had a high growth rate, with 24 cells dividing in one area under the microscope. Despite undergoing extensive surgery and treatment, the patient sadly passed away nine months later, highlighting that even early-stage tumors with similar features to less aggressive cancers can be very dangerous.
Who this helps: This information is valuable for doctors and patients facing similar cancer diagnoses.
Intratesticular serous cystadenoma of borderline malignancy. A pathological, histochemical and DNA content study of a case with long-term follow-up.
1993
Virchows Archiv. A, Pathological anatomy and histopathology
De Nictolis M, Tommasoni S, Fabris G, Prat J
Plain English Researchers studied a 61-year-old man with a painless lump in his testicle, which turned out to be a rare type of tumor called an intratesticular serous borderline tumor. After the tumor was removed, tests showed that it had certain markers indicating it was less aggressive and the patient's DNA analysis showed unusual cell content, but he still had a good recovery. This is important because it suggests that even if these tumors have complex DNA patterns, they are generally not likely to be harmful.
Who this helps: This helps patients with similar testicular tumors and their doctors.
[Angiomatoid malignant fibrous histiocytoma. Clinico-pathologic and immunohistochemical study of a case].
1993
Minerva chirurgica
De Nictolis M, Tommasoni S, Goteri G, Giangiacomi M, Attardo S +5 more
Plain English This study looked at a rare tumor called angiomatoid malignant fibrous histiocytoma in a 10-year-old girl. The tumor, which was 2.5 x 1.0 cm in size, was successfully removed through surgery, and four years later, the patient remains healthy without any signs of the tumor returning. This matters because it highlights that surgical removal is an effective treatment for this type of tumor, ensuring better outcomes for young patients.
Who this helps: Patients with angiomatoid malignant fibrous histiocytoma and their families.
Serous borderline tumors of the ovary. A clinicopathologic, immunohistochemical, and quantitative study of 44 cases.
1992
Cancer
de Nictolis M, Montironi R, Tommasoni S, Carinelli S, Ojeda B +2 more
Plain English This study looked at 44 cases of serous borderline tumors (SBT) of the ovary to understand their characteristics and outcomes. It found that while most patients were tumor-free 1 to 14 years after surgery, those with invasive peritoneal implants had a higher risk of dying from the disease, with four patients passing away within 3 to 9 years. Overall, the research showed that SBT is usually not aggressive, but those with invasive features can be serious.
Who this helps: This helps patients with ovarian tumors and their doctors in understanding the risk levels associated with different types of tumor behavior.